Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zoe Maskell"'
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Pre-surgical window studies rely on the accurate quantification of biomarkers as surrogates of disease response. In endometrial cancer, this has traditionally involved comparing immunohistochemical expression in diagnostic endometrial biopsies with t
Externí odkaz:
https://doaj.org/article/aff93b75b30647f9b11c39048a605b72
Autor:
Roya Behrouzi, Neil A. J. Ryan, Chloe E. Barr, Abigail E. Derbyshire, Y. Louise Wan, Zoe Maskell, Katie Stocking, Philip W. Pemberton, James Bolton, Rhona J. McVey, Emma J. Crosbie
Publikováno v:
Cancers, Vol 12, Iss 2, p 276 (2020)
The levonorgestrel-releasing intrauterine system (LNG-IUS) is a conservative management option for atypical hyperplasia (AH) and low grade early stage endometrial cancer (EEC), but around 1 in 3 patients fail to respond to treatment. The aim of this
Externí odkaz:
https://doaj.org/article/ffb74bf7630b483f9cb8a6137982694e
Autor:
Emma J. Crosbie, Henry C. Kitchener, W. David Ryder, Joseph Shaw, Philip W. Pemberton, Richard J. Slade, Rahamatulla Latheef, Kyle Gilmour, Sean Burns, Saad Ali, Jennifer L. Allen, Vanitha N. Sivalingam, Zoe Maskell, Sarah J. Kitson
Immunohistochemistry staining protocols
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ab8694cf7bee89d7f1ca48ac3f3d42
https://doi.org/10.1158/1078-0432.22471361.v1
https://doi.org/10.1158/1078-0432.22471361.v1
Autor:
Emma J. Crosbie, Henry C. Kitchener, W. David Ryder, Joseph Shaw, Philip W. Pemberton, Richard J. Slade, Rahamatulla Latheef, Kyle Gilmour, Sean Burns, Saad Ali, Jennifer L. Allen, Vanitha N. Sivalingam, Zoe Maskell, Sarah J. Kitson
Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aedb79883eeb151c50db31289da530e
https://doi.org/10.1158/1078-0432.22471364
https://doi.org/10.1158/1078-0432.22471364
Autor:
Emma J. Crosbie, Henry C. Kitchener, W. David Ryder, Joseph Shaw, Philip W. Pemberton, Richard J. Slade, Rahamatulla Latheef, Kyle Gilmour, Sean Burns, Saad Ali, Jennifer L. Allen, Vanitha N. Sivalingam, Zoe Maskell, Sarah J. Kitson
Purpose:Endometrioid endometrial cancer is strongly associated with obesity and insulin resistance. Metformin, an insulin sensitizer, reduces endometrial tumor growth in vitro. Presurgical window studies allow rapid in vivo assessment of antitumor ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d0a0625798f85b0fada3a1fc80da235
https://doi.org/10.1158/1078-0432.c.6527864.v1
https://doi.org/10.1158/1078-0432.c.6527864.v1
Autor:
Y Louise Wan, Roya Behrouzi, Chloe E Barr, Emma J Crosbie, Rhona J McVey, Zoe Maskell, Neil A J Ryan, Katie Stocking, James Bolton, Abigail E. Derbyshire, Philip W. Pemberton
Publikováno v:
Behrouzi, R, Ryan, N, Barr, C, Derbyshire, A, Wan, L, Maskell, Z, Stocking, K, Pemberton, P, Bolton, J, McVey, R J & Crosbie, E 2020, ' Baseline serum HE4 but not tissue HE4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer ', Cancers . https://doi.org/10.3390/cancers12020276
Cancers
Behrouzi, R, Ryan, N A J, Barr, C E, Derbyshire, A E, Wan, Y L, Maskell, Z, Stocking, K, Pemberton, P W, Bolton, J, McVey, R J & Crosbie, E J 2020, ' Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer ', Cancers, vol. 12, no. 2 . https://doi.org/10.3390/cancers12020276
Cancers, Vol 12, Iss 2, p 276 (2020)
Volume 12
Issue 2
Cancers
Behrouzi, R, Ryan, N A J, Barr, C E, Derbyshire, A E, Wan, Y L, Maskell, Z, Stocking, K, Pemberton, P W, Bolton, J, McVey, R J & Crosbie, E J 2020, ' Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer ', Cancers, vol. 12, no. 2 . https://doi.org/10.3390/cancers12020276
Cancers, Vol 12, Iss 2, p 276 (2020)
Volume 12
Issue 2
The levonorgestrel-releasing intrauterine system (LNG-IUS) is a conservative management option for atypical hyperplasia (AH) and low grade early stage endometrial cancer (EEC), but around 1 in 3 patients fail to respond to treatment. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7369e016706a52ad14911956f2ea52b2
https://doi.org/10.3390/cancers12020276
https://doi.org/10.3390/cancers12020276
Autor:
Sarah J, Kitson, Zoe, Maskell, Vanitha N, Sivalingam, Jennifer L, Allen, Saad, Ali, Sean, Burns, Kyle, Gilmour, Rahamatulla, Latheef, Richard J, Slade, Philip W, Pemberton, Joseph, Shaw, W David, Ryder, Henry C, Kitchener, Emma J, Crosbie
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(8)
PURPOSE: Endometrioid endometrial cancer is strongly associated with obesity and insulin resistance. Metformin,an insulin sensitizer, reduces endometrial tumor growth in vitro. Presurgical window studies allow rapid in vivo assessment of antitumor ac
Autor:
Joseph Shaw, Sarah Kitson, Richard J Slade, Rahamatulla Latheef, Saad Ali, Henry C Kitchener, Jennifer L. Allen, Vanitha N Sivalingam, Sean Burns, Emma J Crosbie, Phil Pemberton, Kyle Gilmour, W David J Ryder, Zoe Maskell
Publikováno v:
SSRN Electronic Journal.
Background: Endometrial cancer is strongly associated with obesity and insulin resistance. Metformin, an insulin sensitizer, reduces endometrial tumour growth in vitro. Pre-surgical window studies allow rapid in vivo assessment of anti-tumour activit